spec sheet12 rows
Pregnenolone sulfate (PregS) is an endogenous excitatory neurosteroid (a steroid synthesized in and acting upon the nervous system) formed by sulfation of pregnenolone at its 3beta-hydroxyl group. It is among the most intensively studied neurosteroids in ion-channel pharmacology, acting simultaneously as a positive allosteric modulator of N-methyl-D-aspartate (NMDA) receptors that contain GluN2A or GluN2B subunits (the principal glutamate-gated channels underlying synaptic plasticity), a negative allosteric modulator of GABA-A receptors (the brain's main inhibitory chloride channels), a low-affinity agonist of the sigma-1 receptor (an intracellular chaperone protein) and the prototypical agonist of the TRPM3 cation channel. Through these convergent actions it enhances glutamatergic transmission, hippocampal acetylcholine release, long-term potentiation and memory consolidation in animal models, which underlies its reputation as a pro-cognitive neurosteroid. Its physiological concentrations, and even its unambiguous presence in mammalian brain, remain debated, so much of the evidence base derives from experimental administration rather than demonstrated endogenous signaling.
- Enhances NMDA-dependent synaptic plasticity
- Robust memory enhancer in animal models
- Sigma-1 agonism linked to neuroprotection
- One of the brain's main excitatory neurosteroids
- Enhances memory acquisition, consolidation and retention across rodent learning tasks
- Potentiates NMDA-receptor signaling and hippocampal long-term potentiation, the cellular substrate of learning
- Increases acetylcholine release from basal forebrain and hippocampal circuits, supporting attention and memory
- Reverses amnesia produced by NMDA blockers and cholinergic antagonists in animal models
- Neuroprotective at low concentrations, largely through sigma-1 receptor activation
- Restores signaling of certain disease-causing GluN2B (GRIN2B) NMDA-receptor variants in laboratory models
- Excitatory tilt could lower seizure threshold in theory
- Proconvulsant; lowers the seizure threshold in rodents by combining NMDA potentiation with GABA-A inhibition
- TRPM3 agonism links it to pain and thermal hypersensitivity
Overview
The archetypal excitatory neurosteroid: a memory-enhancing NMDA-receptor potentiator and GABA-A blocker whose endogenous brain physiology is as contested as its receptor pharmacology is well characterized.
- adding a sulfate group flips a calming neurosteroid into an excitatory, memory-boosting one.
- it turns NMDA glutamate receptors up while turning GABA-A receptors down, the opposite of allopregnanolone.
- it is one of the endogenous agonists of the TRPM3 ion channel.
- despite being a strong memory enhancer in rodents, sulfated steroids cross into the brain poorly, so oral use may not reproduce the effect.
- Injected into limbic structures shortly after learning, PregS enhances memory at vanishingly small doses; in one classic study the amygdala was by far the most sensitive site, responding in the femtomole range.
- PregS is the prototypical agonist of TRPM3, an ion channel whose roles reach far outside the brain; the same steroid that tunes NMDA receptors also triggers insulin release from pancreatic beta cells and regulates vascular smooth muscle contraction.
- Whether free pregnenolone sulfate even exists in mammalian brain is genuinely disputed; high-resolution mass spectrometry designed to prevent cholesterol autoxidation failed to detect it in rodent brain, implying that some classic neurosteroid measurements were artifacts.
- Its synthesis is under peptide control: neuropeptide Y suppresses sulfated neurosteroid production in the hypothalamus through Y1 receptors, a rare instance of a peptide transmitter gating steroid biosynthesis.
Mechanism
Pregnenolone sulfate is biosynthesized from cholesterol, which is delivered to the inner membrane by the translocator protein (TSPO) and the steroidogenic acute regulatory protein (StAR) and cleaved to pregnenolone by the side-chain cleavage enzyme CYP11A1 (cytochrome P450scc). Pregnenolone is then conjugated at its 3beta-hydroxyl group by cytosolic hydroxysteroid sulfotransferases, principally SULT2A1 in peripheral tissues and SULT2B1b in the central nervous system, using 3'-phosphoadenosine-5'-phosphosulfate (PAPS) as the sulfate donor. The reaction is reversible through steroid sulfatase (STS), which regenerates free pregnenolone; desulfation also feeds downstream neurosteroidogenesis toward progesterone, allopregnanolone and dehydroepiandrosterone, placing PregS at a branch point of neurosteroid metabolism. This sulfation and desulfation cycle, together with hypothalamic control by neuropeptide Y acting at Y1 receptors, positions PregS as a locally and dynamically regulated signal rather than a static circulating hormone.
Pharmacologically, PregS is defined by opposing, subunit-selective actions at ionotropic receptors. At the it is a positive modulator of assemblies containing GluN2A or GluN2B, increasing channel open probability and -evoked calcium influx, whereas it inhibits assemblies containing GluN2C or GluN2D; this bidirectional selectivity is conferred by a steroid modulatory domain (designated SMD1) on the GluN2 subunit that is functionally coupled to the receptor's proton sensor and to the GluN1 exon-5 cassette. Beyond direct gating, low nanomolar to picomolar concentrations of PregS drive non-canonical trafficking of functional receptors to the neuronal surface through a mechanism dependent on G proteins and intracellular calcium, and activate (cyclic monophosphate response element binding protein) signaling, linking the steroid to activity-dependent plasticity. At -A receptors PregS is a non-competitive negative modulator that binds a site distinct from the potentiating site used by allopregnanolone and barbiturates, accelerating desensitization and reducing inhibitory chloride current; the combination of NMDA potentiation with GABA-A inhibition makes its net central effect pro-excitatory.
PregS is additionally a low-affinity of the sigma-1 receptor, through which it potentiates -evoked noradrenaline and release and produces neuroprotective and anti-amnesic effects, and it is the canonical agonist of TRPM3 (transient receptor potential melastatin 3), a calcium-permeable cation channel that couples the steroid to presynaptic glutamate release, pancreatic secretion, vascular tone and thermal nociception. More recent work shows that PregS also potentiates the inwardly rectifying potassium channel Kir2.3 and tetrodotoxin-resistant sodium channels (largely Nav1.8 and Nav1.9), extending its ionophore pharmacology well beyond the classical glutamate and axis. Its closest active relatives are pregnenolone itself and the downstream sulfated androgen dehydroepiandrosterone sulfate (DHEAS), which shares its excitatory profile as a GABA-A and sigma agonist.
receptor fingerprint
(GluN2A/GluN2B-containing)positive allosteric modulator; enhances NMDA current and, downstream, synaptic plasticity
-A receptornegative allosteric modulator; the opposite of the calming pregnane neurosteroids
Sigma-1 receptoragonist
TRPM3 cation channelagonist
(GluN2A / GluN2B subtypes)Positive allosteric modulator
(GluN2C / GluN2D subtypes)Negative allosteric modulator
Tetrodotoxin-resistant sodium channels (Nav1.8 / Nav1.9)Potentiator
Dosingtypical ranges, not medical advice
interested in protocols and clinical dosages? make an account to see them! ^_^
Safetyrisks and cautions, not medical advice
As an endogenous molecule, pregnenolone sulfate is not an approved drug and has no formal human safety dossier as a discrete agent, in contrast to its parent pregnenolone, which is sold as an oral supplement. Its excitatory pharmacology carries a mechanistically predictable liability: because it potentiates NMDA receptors while inhibiting GABA-A receptors, it is proconvulsant in rodents and lowers the seizure threshold, and at high experimental concentrations it can aggravate NMDA-mediated excitotoxic neuronal death.
These actions are biphasic and concentration dependent, since at low nanomolar exposure the same molecule is neuroprotective, largely through sigma-1 receptor signaling. Agonism at TRPM3 additionally couples PregS to thermal and inflammatory pain, and emerging work implicates PregS-sensitive channels in migraine-relevant sensory excitability. Because robust human pharmacokinetic and toxicity data are lacking and the charged sulfate ester penetrates the blood-brain barrier poorly on its own, PregS remains chiefly a research neurosteroid rather than a therapeutic entity.
History
Pregnenolone sulfate emerged from the neurosteroid concept advanced by Etienne-Emile Baulieu, who in the 1980s reported that sulfated steroids persist in mammalian brain independently of the peripheral endocrine glands. Its receptor pharmacology was defined by two landmark findings: Maria Majewska and colleagues showed in 1987 that PregS antagonizes the GABA-A receptor complex, and the laboratory of David Farb established in 1991 that it is a positive allosteric modulator at the NMDA receptor, making it one of the first recognized endogenous ligands to act oppositely on the brain's principal excitatory and inhibitory channels.
Behavioral studies by Flood, Morley and Roberts in the early 1990s demonstrated potent memory enhancement in mice, and in 1997 Vallee and Mayo correlated low endogenous hippocampal PregS with cognitive decline in aged rats, cementing its pro-mnemonic reputation. The finding in 2008 that PregS is the physiological agonist of the TRPM3 channel opened an entirely separate ionotropic pharmacology outside the nervous system. In parallel, rigorous mass spectrometry by Liere, Schumacher and colleagues questioned whether free PregS is genuinely present in rodent brain, launching a controversy that remains unresolved and that reframes much of the early work as pharmacological rather than physiological.
Reputation
Within neuropharmacology, pregnenolone sulfate holds the status of a benchmark experimental neurosteroid; it is the reference agonist for the TRPM3 channel and a standard tool for dissecting subunit-selective modulation of NMDA and GABA-A receptors. In nootropic and supplement circles it is frequently described as a memory-enhancing, pro-cognitive agent, although that reputation rests almost entirely on rodent data and is often conflated with its orally available parent, pregnenolone, which is the form actually sold to consumers.
Enthusiasm is tempered by two practical realities: PregS is a charged, water-soluble sulfate ester that crosses the blood-brain barrier poorly and is not marketed as a discrete oral product, and its endogenous concentration in brain remains scientifically contested. As a result, most clinical translation has centered on pregnenolone and on synthetic analogues engineered to keep the excitatory, memory-promoting profile while improving drug-like properties, with PregS itself regarded as a mechanistically illuminating but pharmacokinetically awkward molecule.
Subjective profileweighing the evidence above
Fascinating neurosteroid, useless as a supplement. The charged sulfate is poorly absorbed and enters the brain inefficiently, so the striking animal memory results came from injection, and its NMDA-up, GABA-down profile is proconvulsant in rodents. Anyone drawn to this should be looking at plain pregnenolone instead.
Resources
This entry is here for reference.
Research
- 1987first citedPregnenolone-sulfate: an endogenous antagonist of the gamma-aminobutyric acid receptor complex…
- 2025most recentPregnenolone sulfate potentiates tetrodotoxin-resistant Na(+) channels to increase the excitabi…
- 1.Pregnenolone sulfate potentiates the inwardly rectifying K+ channel Kir2.3
- 2.Pregnenolone sulfate: a positive allosteric modulator at the N-methyl-D-aspartate receptor.
- 3.Pregnenolone-sulfate: an endogenous antagonist of the gamma-aminobutyric acid receptor complex in brain?
- 4.Sulfated and unsulfated steroids modulate gamma-aminobutyric acidA receptor function through distinct sites.
- 5.Inhibition of the NMDA response by pregnenolone sulphate reveals subtype selective modulation of NMDA receptors by sulphated steroids.
- 6.A steroid modulatory domain on NR2B controls N-methyl-D-aspartate receptor proton sensitivity.
- 7.A steroid modulatory domain in NR2A collaborates with NR1 exon-5 to control NMDAR modulation by pregnenolone sulfate and protons.
- 8.The neuroactive steroid pregnenolone sulfate stimulates trafficking of functional N-methyl D-aspartate receptors to the cell surface via a noncanonical, G protein, and Ca2+-dependent mechanism.
- 9.A role for picomolar concentrations of pregnenolone sulfate in synaptic activity-dependent Ca2+ signaling and CREB activation.
- 10.Mechanism of conductance control and neurosteroid binding in NMDA receptors.
- 11.Rescuing tri-heteromeric NMDA receptor function: the potential of pregnenolone-sulfate in loss-of-function GRIN2B variants.
- 12.Pregnenolone sulfate analogues differentially modulate GABA(A) receptor closed/desensitised states.
31 listed here; entry last updated August 2026
Reviews
My notesprivate to this device
FAQ
How is pregnenolone sulfate different from pregnenolone?
chemically it is pregnenolone with a sulfate group attached, and pharmacologically it is almost the opposite: plain pregnenolone is mostly a hormone precursor, while the sulfate is a direct, excitatory neuromodulator that boosts NMDA receptors and blocks GABA-A.
Why is it called excitatory?
because it turns up NMDA glutamate receptors and turns down GABA-A receptors, tilting the brain toward activation and plasticity, unlike the calming pregnane neurosteroids.
Does it improve memory?
strongly in animals; it is one of the most reliable pro-cognitive neurosteroids in rodent learning tasks. convincing human cognition trials of the sulfate itself are lacking.
Can I take it as a nootropic?
there is no validated human dose, and as a sulfated steroid it crosses into the brain poorly, so oral products may not deliver the central effect. treat claims skeptically; it is research biology, not a proven supplement.
What receptors does it hit?
NMDA receptors (positive), GABA-A receptors (negative), the sigma-1 receptor (agonist) and the TRPM3 channel (agonist).
Is it the same as the pregnenolone supplement on shelves?
no; those are usually plain pregnenolone. the sulfate is a distinct molecule with a distinct, excitatory pharmacology, and the two are often confused in marketing.
Is pregnenolone sulfate the same as pregnenolone?
No. Pregnenolone sulfate is the 3-sulfate ester of pregnenolone. The added sulfate group makes it water-soluble and pharmacologically distinct: PregS directly modulates NMDA, GABA-A, sigma-1 and TRPM3 channels, whereas unconjugated pregnenolone acts mainly as a precursor that the body converts into other steroids. The two interconvert through sulfotransferase and steroid sulfatase enzymes.
Why is it called an excitatory neurosteroid?
Because its two dominant central actions both raise neuronal excitability: it potentiates NMDA receptors that contain GluN2A or GluN2B subunits, increasing excitatory glutamate signaling, and it simultaneously inhibits GABA-A receptors, reducing inhibition. This is the opposite of inhibitory neurosteroids such as allopregnanolone, which strongly potentiate GABA-A receptors.
Does taking a pregnenolone supplement raise brain pregnenolone sulfate?
Not reliably. Oral pregnenolone is the parent compound and can be partly sulfated in the body, but PregS itself crosses the blood-brain barrier poorly, and human data linking oral pregnenolone to meaningful changes in brain PregS are absent. Most PregS evidence comes from administering the compound directly in animals.
Is pregnenolone sulfate really present in the human brain?
This is genuinely debated. Early assays reported measurable PregS in brain, but later mass spectrometry that controlled for cholesterol autoxidation failed to detect free PregS in rodent brain, suggesting some earlier values were artifacts. Its standing as a bona fide endogenous brain signal remains unresolved.
Could it improve memory or cognitive aging in people?
The rationale is strong in animals, where PregS enhances memory and low hippocampal levels track with age-related cognitive decline, but there are no controlled human trials of PregS itself. Clinical work has instead focused on the parent pregnenolone and on synthetic analogues designed to preserve the pro-cognitive profile while improving drug-like properties.
Limitations of the evidence
- No validated human safety data
- No established human safety or dosing data as a discrete compound
Adverse effects
- Excitatory tilt could lower seizure threshold in theory
- Proconvulsant; lowers the seizure threshold in rodents by combining NMDA potentiation with GABA-A inhibition
- TRPM3 agonism links it to pain and thermal hypersensitivity
Notes and cautions
- Sulfated steroids penetrate the brain poorly (bioavailability doubt)
- Often conflated with plain pregnenolone in marketing
- May worsen excitotoxic neuronal injury at high concentrations
- Pro-arousal and anxiogenic effects reported in some animal paradigms
- Poor oral absorption and limited penetration of the blood-brain barrier constrain practical use